Published in J Thromb Haemost on March 23, 2009
Scientific considerations in the review and approval of generic enoxaparin in the United States. Nat Biotechnol (2013) 0.97
Biosimilar low molecular weight heparin products. J Thromb Haemost (2009) 0.97
Update on the safety and bioequivalence of biosimilars - focus on enoxaparin. Drug Healthc Patient Saf (2013) 0.80
Increased fetal loss in women with heritable thrombophilia. Lancet (1996) 3.34
Incidence of venous thromboembolism verified by necropsy over 30 years. BMJ (1991) 3.14
Solitary aneurysms of the iliac arterial system: an estimate of their frequency of occurrence. J Vasc Surg (1989) 2.69
Transmission of hepatitis C with pasteurised factor VIII. Lancet (1992) 2.62
A 30-year survey of pulmonary embolism verified at autopsy: an analysis of 1274 surgical patients. Br J Surg (1985) 2.61
Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. J Vasc Surg (2010) 2.52
Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Ann Intern Med (2001) 2.37
A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med (1992) 2.27
Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. J Biol Chem (1993) 2.07
Real-world variability in dabigatran levels in patients with atrial fibrillation. J Thromb Haemost (2015) 2.07
Recurrent thromboembolism in pregnancy and puerperium. Is there a need for thromboprophylaxis? Am J Obstet Gynecol (1989) 2.06
Graduated compression stockings to treat acute leg pain associated with proximal DVT. A randomised controlled trial. Thromb Haemost (2014) 2.02
Ruptured abdominal aortic aneurysm: a population-based study. J Vasc Surg (1993) 2.00
Induction of crisis forms in the human malaria parasite Plasmodium falciparum by gamma-interferon-activated, monocyte-derived macrophages. J Immunol (1984) 1.95
Redistribution of membrane proteins in isolated mouse intestinal epithelial cells. J Cell Biol (1980) 1.94
[Problems of interpretation in vascular surgery]. Lakartidningen (1993) 1.94
Antithrombotic therapy for venous thromboembolic disease. Chest (2001) 1.94
Cranial nerve injuries after carotid artery surgery. A prospective study of 663 operations. Eur J Vasc Endovasc Surg (1995) 1.86
A primary intrapelvic hydatid cyst presenting with foot drop and a gluteal swelling: a case report. J Bone Joint Surg Br (1998) 1.82
Gradient polyacrylamide gel electrophoresis for determination of molecular weights of heparin preparations and low-molecular-weight heparin derivatives. J Pharm Sci (1992) 1.80
Venous and non-venous leg ulcers: clinical history and appearance in a population study. Br J Surg (1994) 1.79
A randomized study comparing the efficacy and safety of nadroparin 2850 IU (0.3 mL) vs. enoxaparin 4000 IU (40 mg) in the prevention of venous thromboembolism after colorectal surgery for cancer. J Thromb Haemost (2006) 1.78
Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine. Cancer Res (1996) 1.68
Antithrombotic therapy for venous thromboembolic disease. Chest (1998) 1.67
Conformational flexibility: a new concept for explaining binding and biological properties of iduronic acid-containing glycosaminoglycans. Trends Biochem Sci (1988) 1.66
Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin. BMJ (1991) 1.65
Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation (2001) 1.64
Structure and biological activity of heparin. Adv Carbohydr Chem Biochem (1985) 1.63
Selexipag for the Treatment of Pulmonary Arterial Hypertension. N Engl J Med (2015) 1.62
Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity. Biochem Biophys Res Commun (1983) 1.62
A prospective comparison of duplex ultrasonography, captopril renography, MRA, and CTA in assessing renal artery stenosis. Acta Radiol (2006) 1.62
Correlation of tumor O6 methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: a Southwest Oncology Group study. J Clin Oncol (1998) 1.61
Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence. Int Angiol (2001) 1.59
Changing concepts in renovascular surgery. Br J Surg (1989) 1.58
Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series. J Thromb Haemost (2011) 1.54
Conformer populations of L-iduronic acid residues in glycosaminoglycan sequences. Carbohydr Res (1990) 1.53
Deep vein thrombosis of the axillary-subclavian veins: epidemiologic data, effects of different types of treatment and late sequelae. Eur J Vasc Surg (1988) 1.53
Prevalence of abdominal aortic aneurysm in the offspring of patients dying from aneurysm rupture. Br J Surg (1992) 1.51
Nationwide study of the outcome of popliteal artery aneurysms treated surgically. Br J Surg (2007) 1.51
Iatrogenic vascular injuries in Sweden. A nationwide study 1987-2005. Eur J Vasc Endovasc Surg (2007) 1.49
Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomized comparison. The North American Fragmin Trial Investigators. Arch Intern Med (2000) 1.48
Validity of an exam assessment in surgical skill: EBSQ-VASC pilot study. Eur J Vasc Endovasc Surg (2004) 1.48
A randomized trial of the low-molecular-weight heparin certoparin to prevent restenosis following coronary angioplasty. J Invasive Cardiol (2001) 1.48
Rhoptry secretion of membranous whorls by Plasmodium falciparum merozoites. Am J Trop Med Hyg (1986) 1.47
Short term effect of recombinant tissue plasminogen activator in patients with hemodynamically stable acute pulmonary embolism: results of a meta-analysis involving 464 patients. Thromb Res (2009) 1.46
Randomized clinical trial of routine preoperative duplex imaging before varicose vein surgery. Br J Surg (2005) 1.46
Inhibition of heparin-resistant microarterial thrombosis by recombinant hirudin: a specific thrombin inhibitor. Plast Reconstr Surg (1995) 1.46
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Haemost (2009) 1.45
Problems of oral anticoagulation in an adult with homozygous protein C deficiency and late onset of thrombosis. Thromb Haemost (1993) 1.44
A European view on the North American fifth consensus on antithrombotic therapy. Chest (2000) 1.43
Insurance claims after vascular surgery in Sweden. Eur J Vasc Endovasc Surg (2011) 1.43
Comparison of two PF4/heparin ELISA assays for the laboratory diagnosis of heparin-induced thrombocytopenia. Semin Thromb Hemost (1999) 1.42
A novel congenital haemostatic defect: combined factor VII and factor XI deficiency. Blood Coagul Fibrinolysis (1992) 1.42
Antithrombin-III-Stockholm: a codon 392 (Gly----Asp) mutation with normal heparin binding and impaired serine protease reactivity. Blood (1992) 1.41
1H and 13C NMR spectral assignments of the major sequences of twelve systematically modified heparin derivatives. Carbohydr Res (1996) 1.41
Acute thrombogenicity of collagen coating of dacron grafts: an experimental study in sheep. Eur J Vasc Surg (1992) 1.41
2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working group. Ann Oncol (2009) 1.41
Laboratory assays for the evaluation of recombinant hirudin. Haemostasis (1991) 1.40
Vitamin K antagonists and cancer: rebuttal. J Thromb Haemost (2004) 1.40
An experimental porcine model of partial ischaemia of the distal colon. Eur J Surg (1997) 1.39
The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C nuclear-magnetic-resonance studies. Biochem J (1981) 1.39
Cerebral infarction and familial protein S deficiency. Stroke (1990) 1.39
Endometriosis of the round ligament: description of a clinical case and review of the literature. Hernia (2005) 1.38
Rapid aequorin loading into platelets in the presence of DMSO--characteristics of the responses (changes in light transmission and in calcium) to various agonists. Thromb Haemost (1991) 1.38
Complications after carotid endarterectomy are related to surgical errors in less than one-fifth of cases. Swedvasc--The Swedish Vascular Registry and The Quality Committee for Carotid Artery Surgery. Eur J Vasc Endovasc Surg (1999) 1.38
An analysis of contact-service in the Migrant Health Service Referral System (MHSRS). Am J Public Health (1971) 1.38
Increasing prevalence of abdominal aortic aneurysms. A necropsy study. Eur J Surg (1992) 1.38
Plasmodium berghei sporozoite invasion is blocked in vitro by sporozoite-immobilizing antibodies. Infect Immun (1986) 1.37
Autopsy-verified pulmonary embolism in a surgical department: analysis of the period from 1951 to 1988. Br J Surg (1991) 1.36
Fatal nonocclusive mesenteric ischaemia: population-based incidence and risk factors. J Intern Med (2006) 1.35
Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators. Arch Intern Med (2000) 1.34
Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: a prospective randomized study. J Vasc Surg (1993) 1.33
Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy. J Clin Oncol (1989) 1.33
Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized. Br J Haematol (1999) 1.32
Deep venous thrombosis and occult malignancy: an epidemiological study. BMJ (1994) 1.30
Hypercoagulable state and thromboembolism following warfarin withdrawal in post-myocardial-infarction patients. Eur Heart J (1991) 1.28
Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen. Thromb Haemost (1995) 1.28
Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparin. Proc Natl Acad Sci U S A (2000) 1.27
Incidence and clinical presentation of bowel ischaemia after aortoiliac surgery--2930 operations from a population-based registry in Sweden. Eur J Vasc Endovasc Surg (1996) 1.26
Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment. Atherosclerosis (1990) 1.26
Arterial complications after knee arthroplasty: 4 cases and a review of the literature. Acta Orthop Scand (1996) 1.25
Intensive initial oral anticoagulation and shorter heparin treatment in deep vein thrombosis. Thromb Haemost (1984) 1.24
[Coagulation disorders after reinjection of concentrated ascitic fluid. Preliminary study]. Med Chir Dig (1973) 1.22
Isolation and characterization of human heparin. Biochemistry (1992) 1.21
Controversial glycosaminoglycan conformations. Nature (1986) 1.20
Small abnormal echos after mitral valve replacement with bileaflet mechanical prostheses: predisposing factors and effect on thromboembolism. J Heart Valve Dis (1993) 1.19
Vascular complications after total hip arthroplasty. Acta Orthop Scand (1983) 1.19
Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery. Br J Surg (2005) 1.19
Self-assessment of technical skill in surgery: the need for expert feedback. Ann R Coll Surg Engl (2008) 1.18
The antiaggregating and antithrombotic activity of ticlopidine is potentiated by aspirin in the rat. Thromb Haemost (1996) 1.17
Risk factors for intestinal ischaemia after aortoiliac surgery: a combined cohort and case-control study of 2824 operations. Eur J Vasc Endovasc Surg (1997) 1.17
Contribution of factor VII genotype to activated FVII levels. Differences in genotype frequencies between northern and southern European populations. Arterioscler Thromb Vasc Biol (1997) 1.17
Oligosaccharide mapping of low molecular weight heparins: structure and activity differences. J Med Chem (1990) 1.16
Studies on the ultrastructure of fibrin lacking fibrinopeptide B (beta-fibrin). Blood (1987) 1.16
Successful progressive anticoagulation in a severe protein C deficiency and previous skin necrosis at the initiation of oral anticoagulant treatment. Thromb Haemost (1984) 1.16
Thrombin structure and function: why thrombin is the primary target for antithrombotics. Blood Coagul Fibrinolysis (1991) 1.15
Incidence and prevalence of abdominal aortic aneurysms, estimated by necropsy studies and population screening by ultrasound. Ann N Y Acad Sci (1996) 1.14
Incidence of acute thrombo-embolic occlusion of the superior mesenteric artery--a population-based study. Eur J Vasc Endovasc Surg (2004) 1.13
Diameter and compliance in the male human abdominal aorta: influence of age and aortic aneurysm. Eur J Vasc Surg (1992) 1.13